Article

Nerve growth factor receptor identifies a basal subpopulation linked to poor prognosis and reduced immunotherapy responses in bladder cancer

2026-05-18

Abstract excerpt

<h4>Purpose</h4> Bladder cancer (BLCA) is a heterogeneous tumor type. Only one third of muscle-invasive (MIBC) patients respond to immune checkpoint inhibitors (ICIs). Reliable resistance markers are needed to guide clinical decisions. We investigated the nerve growth factor receptor (NGFR) in BLCA and analyzed its correlation with disease progression and response to immunotherapy. <h4>Experimental Design</h4> W...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: cb978af6-096c-5771-ab6c-7dbaa62234fd
DOI: 10.64898/2026.05.14.725085

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Nerve growth factor receptor identifies a basal subpopulation linked to poor prognosis and reduced immunotherapy responses in bladder cancerDOI 10.64898/2026.05.14.725085Read

EGFR as a potential therapeutic target for a subset of muscle-invasive bladder cancers presenting a basal-like phenotype.Semantic proximity Read

A spatially resolved whole-layers landscape of bladder cancer deciphers dynamic invasive progressionSemantic proximity Read

Construction of a Novel T Cell Subtype with Immunotherapeutic Value in Bladder Cancer and a Neural Network-Based Prognostic ModelSemantic proximity Read

Characterization of the tumor-infiltrating immune repertoire in muscle invasive bladder cancerSemantic proximity Read

Molecular Subtypes of Bladder Cancer.Semantic proximity Read

The Impact of FGFR3 Alterations on the Tumor Microenvironment and the Efficacy of Immune Checkpoint Inhibitors in Bladder CancerSemantic proximity Read

Integrating single-cell RNA-seq to identify fibroblast-based molecular subtypes for predicting prognosis and therapeutic response in bladder cancerSemantic proximity Read

Data-mining-based biomarker evaluation and experimental validation of SHTN1 for bladder cancerSemantic proximity Read

Epithelial cell diversity and immune remodeling in bladder cancer progression: insights from single-cell transcriptomicsSemantic proximity Read

Meta-Analysis of the Luminal and Basal Subtypes of Bladder Cancer and the Identification of Signature Immunohistochemical Markers for Clinical Use.Semantic proximity Read

Digital spatial profiling of the microenvironment of muscle invasive bladder cancerSemantic proximity Read

Key signaling pathways in the muscle‐invasive bladder carcinoma: Clinical markers for disease modeling and optimized treatmentSemantic proximity Read